JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Brakenhoff, J. P.
Right arrow Articles by Aarden, L. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brakenhoff, J. P.
Right arrow Articles by Aarden, L. A.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

J. Biol. Chem., Vol. 269, Issue 1, 86-93, Jan, 1994

Development of a human interleukin-6 receptor antagonist

JP Brakenhoff, FD de Hon, V Fontaine, E ten Boekel, H Schooltink, S Rose-John, PC Heinrich, J Content and LA Aarden
Department of Autoimmune Diseases, Central Laboratory of the Netherlands Red Cross Blood Transfusion Service, Amsterdam.

Neutralizing monoclonal antibodies specific for human interleukin-6 (IL- 6) bind two distinct sites on the IL-6 protein (sites I and II). Their interference with IL-6 receptor binding suggested that site I is a receptor-binding site of IL-6, whereas site II is important for signal transduction. Mutagenesis of site II could therefore result in the isolation of IL-6 receptor antagonists. To test this hypothesis, a panel of IL-6 mutant proteins was constructed that did not bind to a site II-specific monoclonal antibody. One such site II mutant protein (with double substitution of Gln-160 with Glu and Thr-163 with Pro) was found to be an antagonist of human IL-6. It was inactive on human CESS cells, weakly active on human HepG2 cells, but active on mouse B9 cells. It could specifically antagonize the activity of wild-type IL-6 on CESS and HepG2 cells. The binding affinity of this variant for the 80-kDa IL-6 receptor was similar to that of wild-type IL-6. High affinity binding to CESS cells, however, was abolished, suggesting that the mutant protein is inactive because the complex of the 80-kDa IL-6 receptor and the mutant protein cannot associate with the signal transducer gp130. The human IL-6 antagonist protein may be potentially useful as a therapeutic agent.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
F. Peelman, K. Van Beneden, L. Zabeau, H. Iserentant, P. Ulrichts, D. Defeau, A. Verhee, D. Catteeuw, D. Elewaut, and J. Tavernier
Mapping of the Leptin Binding Sites and Design of a Leptin Antagonist
J. Biol. Chem., September 24, 2004; 279(39): 41038 - 41046.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
W. D. Fairlie, A. D. Uboldi, J. E. McCoubrie, C. C. Wang, E. F. Lee, S. Yao, D. P. De Souza, S. Mifsud, D. Metcalf, N. A. Nicola, et al.
Affinity Maturation of Leukemia Inhibitory Factor and Conversion to Potent Antagonists of Signaling
J. Biol. Chem., January 16, 2004; 279(3): 2125 - 2134.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
H. Li, H. Wang, and J. Nicholas
Detection of Direct Binding of Human Herpesvirus 8-Encoded Interleukin-6 (vIL-6) to both gp130 and IL-6 Receptor (IL-6R) and Identification of Amino Acid Residues of vIL-6 Important for IL-6R-Dependent and -Independent Signaling
J. Virol., April 1, 2001; 75(7): 3325 - 3334.
[Abstract] [Full Text]


Home page
ScienceHome page
D.-c. Chow, X.-l. He, A. L. Snow, S. Rose-John, and K. C. Garcia
Structure of an Extracellular gp130 Cytokine Receptor Signaling Complex
Science, March 16, 2001; 291(5511): 2150 - 2155.
[Abstract] [Full Text]


Home page
J. Virol.Home page
L. Alexander, L. Denekamp, A. Knapp, M. R. Auerbach, B. Damania, and R. C. Desrosiers
The Primary Sequence of Rhesus Monkey Rhadinovirus Isolate 26-95: Sequence Similarities to Kaposi's Sarcoma-Associated Herpesvirus and Rhesus Monkey Rhadinovirus Isolate 17577
J. Virol., April 1, 2000; 74(7): 3388 - 3398.
[Abstract] [Full Text]


Home page
J. Virol.Home page
X. Wan, H. Wang, and J. Nicholas
Human Herpesvirus 8 Interleukin-6 (vIL-6) Signals through gp130 but Has Structural and Receptor-Binding Properties Distinct from Those of Human IL-6
J. Virol., October 1, 1999; 73(10): 8268 - 8278.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
J. A. R. Kaleeba, E. P. Bergquam, and S. W. Wong
A Rhesus Macaque Rhadinovirus Related to Kaposi's Sarcoma-Associated Herpesvirus/Human Herpesvirus 8 Encodes a Functional Homologue of Interleukin-6
J. Virol., July 1, 1999; 73(7): 6177 - 6181.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
J. E. Layton, G. Shimamoto, T. Osslund, A. Hammacher, D. K. Smith, H. R. Treutlein, and T. Boone
Interaction of Granulocyte Colony-stimulating Factor (G-CSF) with Its Receptor. EVIDENCE THAT Glu19 of G-CSF INTERACTS WITH Arg288 OF THE RECEPTOR
J. Biol. Chem., June 18, 1999; 274(25): 17445 - 17451.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
M. Frohm Nilsson, B. Sandstedt, O. Sorensen, G. Weber, N. Borregaard, and M. Stahle-Backdahl
The Human Cationic Antimicrobial Protein (hCAP18), a Peptide Antibiotic, Is Widely Expressed in Human Squamous Epithelia and Colocalizes with Interleukin-6
Infect. Immun., May 1, 1999; 67(5): 2561 - 2566.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
R. A. Gadient and P. H. Patterson
Leukemia Inhibitory Factor, Interleukin 6, and Other Cytokines Using the GP130 Transducing Receptor: Roles in Inflammation and Injury
Stem Cells, May 1, 1999; 17(3): 127 - 137.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
C. Renne, K.-J. Kallen, J. Mullberg, T. Jostock, J. Grotzinger, and S. Rose-John
A New Type of Cytokine Receptor Antagonist Directly Targeting gp130
J. Biol. Chem., October 16, 1998; 273(42): 27213 - 27219.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Hammacher, R. T. Richardson, J. E. Layton, D. K. Smith, L. J. L. Angus, D. J. Hilton, N. A. Nicola, J. Wijdenes, and R. J. Simpson
The Immunoglobulin-like Module of gp130 Is Required for Signaling by Interleukin-6, but Not by Leukemia Inhibitory Factor
J. Biol. Chem., August 28, 1998; 273(35): 22701 - 22707.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. Krebs, H. Griffin, G. Winter, and S. Rose-John
Recombinant Human Single Chain Fv Antibodies Recognizing Human Interleukin-6. SPECIFIC TARGETING OF CYTOKINE-SECRETING CELLS
J. Biol. Chem., January 30, 1998; 273(5): 2858 - 2865.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
U. Horsten, G. Muller-Newen, C. Gerhartz, A. Wollmer, J. Wijdenes, P. C. Heinrich, and J. Grotzinger
Molecular Modeling-guided Mutagenesis of the Extracellular Part of gp130 Leads to the Identification of Contact Sites in the Interleukin-6 (IL-6)·IL-6 receptor·gp130 Complex
J. Biol. Chem., September 19, 1997; 272(38): 23748 - 23757.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. Kalai, F. A. Montero-Julian, J. Grotzinger, V. Fontaine, P. Vandenbussche, R. Deschuyteneer, A. Wollmer, H. Brailly, and J. Content
Analysis of the Human Interleukin-6/Human Interleukin-6 Receptor Binding Interface at the Amino Acid Level: Proposed Mechanism of Interaction
Blood, February 15, 1997; 89(4): 1319 - 1333.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Hammacher, R. J. Simpson, and E. C. Nice
The Interleukin-6 (IL-6) Partial Antagonist (Q159E,T162P)IL-6 Interacts with the IL-6 Receptor and gp130 but Fails to Induce a Stable Hexameric Receptor Complex
J. Biol. Chem., March 8, 1996; 271(10): 5464 - 5473.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. E. I. Proudfoot, C. A. Power, A. J. Hoogewerf, M.-O. Montjovent, F. Borlat, R. E. Offord, and T. N. C. Wells
Extension of Recombinant Human RANTES by the Retention of the Initiating Methionine Produces a Potent Antagonist
J. Biol. Chem., February 2, 1996; 271(5): 2599 - 2603.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. S. Argetsinger, G. W. Hsu, M. G. Myers Jr., N. Billestrup, M. F. White, and C. Carter-Su
Growth Hormone, Interferon-[IMAGE], and Leukemia Inhibitory Factor Promoted Tyrosyl Phosphorylation of Insulin Receptor Substrate-1
J. Biol. Chem., June 16, 1995; 270(24): 14685 - 14692.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. Panayotatos, E. Radziejewska, A. Acheson, R. Somogyi, A. Thadani, W. A. Hendrickson, and N. Q. McDonald
Localization of Functional Receptor Epitopes on the Structure of Ciliary Neurotrophic Factor Indicates a Conserved, Function-related Epitope Topography among Helical Cytokines
J. Biol. Chem., June 9, 1995; 270(23): 14007 - 14014.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Ehlers, F. D. de Hon, H. K. Bos, U. Horsten, Gün. Kurapkat, H. S. van De Leur, J. Grötzinger, A. Wollmer, J. P. J. Brakenhoff, and S. Rose-John
Combining Two Mutations of Human Interleukin-6 That Affect gp130 Activation Results in a Potent Interleukin-6 Receptor Antagonist on Human Myeloma Cells
J. Biol. Chem., April 7, 1995; 270(14): 8158 - 8163.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1994 by the American Society for Biochemistry and Molecular Biology.